Recent

% | $
Quotes you view appear here for quick access.

Alexion Pharmaceuticals, Inc. Message Board

songciti 1 post  |  Last Activity: Apr 26, 2016 10:16 AM Member since: Mar 20, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • songciti by songciti Apr 26, 2016 10:16 AM Flag

    Oppenheimer downgraded the stock to "market perform" from "outperform" and removed its $60 price target, Piper Jaffray downgraded Sarepta to "underweight" and cut its price target to $6 from $15, and SunTrust lowered its rating to "reduce" from "neutral" and slashed its price target to $4 from $14, Barron's reports.
    All three firms wrote that FDA approval is unlikely.

ALXN
125.80-1.50(-1.18%)Jul 22 4:00 PMEDT